Reuters logo
BRIEF-Acrux says U.S. Patent and Trademark Office institutes IPR proceeding against a U.S. Patent
May 2, 2017 / 4:47 AM / 7 months ago

BRIEF-Acrux says U.S. Patent and Trademark Office institutes IPR proceeding against a U.S. Patent

May 2 (Reuters) - Acrux Ltd

* U.S. Patent and Trademark Office has instituted an inter partes review (IPR) proceeding filed by Acrux against U.S. Patent no. 7,214,506

* Patent relates to methods of using various antifungal compounds, including efinaconazole, for treatment of onychomycosis

* U.S. Patent No. 7,214,506 is owned by Kaken Pharmaceutical Co Ltd. and licensed to Valeant Pharmaceuticals International Inc Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below